CSIMarket
 


Leap Therapeutics inc   (LPTX)
Other Ticker:  
 
 

LPTX's EPS from Cont. Operations Growth by Quarter and Year

Leap Therapeutics Inc 's EPS from Cont. Operations results by quarter and year




LPTX EPS from Cont. Operations (in $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December -0.85 -0.11 -0.10 -0.09
III Quarter September -0.51 -0.13 -0.14 -0.09
II Quarter June -0.91 -0.15 -0.12 -0.12
I Quarter March -0.32 -0.09 -0.12 -0.55
FY   -2.59 -0.48 -0.48 -0.85



LPTX EPS from Cont. Operations fourth quarter 2023 Y/Y Growth Comment
Leap Therapeutics inc in the fourth quarter 2023 recorded EPS loss from Cont. Operations of $ -0.85 .

According to the results reported in the fourth quarter 2023, Leap Therapeutics Inc achieved the best EPS from Cont. Operations growth in Major Pharmaceutical Preparations industry. While Leap Therapeutics Inc ' s EPS from Cont. Operations no change of % ranks overall at the positon no. in the fourth quarter 2023.




LPTX EPS from Cont. Operations ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Leap Therapeutics Inc 's fourth quarter 2023 EPS from Cont. Operations $ -0.85 LPTX's Income Statement
Leap Therapeutics Inc 's fourth quarter 2022 EPS from Cont. Operations $ -0.11 Quarterly LPTX's Income Statement
New: More LPTX's historic EPS from Cont. Operations Growth >>


LPTX EPS from Cont. Operations (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




EPS from Cont. Operations fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
EPS from Cont. Operations fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

EPS from Cont. Operations by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Leap Therapeutics Inc 's Q/Q EPS from Cont. Operations Growth


EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


LPTX's IV. Quarter Q/Q EPS from Cont. Operations Comment
Recent EPS loss from Cont. Operations of -0.85 by Leap Therapeutics inc come out even worse if you take a look at -0.51 a quarter before.

Within Major Pharmaceutical Preparations industry Leap Therapeutics inc achieved highest sequential EPS from Cont. Operations growth. While Leap Therapeutics Inc 's EPS from Cont. Operations growth quarter on quarter, overall rank is .


EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


LPTX's IV. Quarter Q/Q EPS from Cont. Operations Comment
IV. Quarter 2023 EPS loss from Cont. Operations of -0.85 by Leap Therapeutics inc look even worse compare to the EPS loss from Cont. Operations -0.51 a quarter before.

Within Major Pharmaceutical Preparations industry Leap Therapeutics inc achieved highest sequential EPS from Cont. Operations growth. While Leap Therapeutics Inc 's EPS from Cont. Operations growth quarter on quarter, overall rank is .


Leap Therapeutics Inc 's 12 Months EPS from Cont. Operations Growth Year on Year


EPS from Cont. Operations TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
Cumulative EPS from Cont. Operations 12 Months Ending $ -2.59 $ -1.85 $ -1.47 $ -0.71 $ -0.48
Y / Y EPS from Cont. Operations Growth (TTM) - - - - -
Year on Year EPS from Cont. Operations Growth Overall Ranking # # # # #
Seqeuential EPS from Cont. Operations Change (TTM) - - - - -
Seq. EPS from Cont. Operations Growth (TTM) Overall Ranking # # # # #




Cumulative EPS from Cont. Operations growth Comment
Leap Therapeutics Inc ' has realized cumulative trailing twelve months EPS loss from Cont. Operations of $ -3 in the Dec 31 2023 period.
The situation is getting worse as the cumulative EPS loss from Cont. Operations is becoming larger from $ -1.85 for the period from Sep 30 2023 to Dec 31 2022 and $ -0.46605191376226 from the TTM period ending Dec 31 2022 Natalie Walsh told.

Leap Therapeutics inc achieved highest trailing twelve month year on year EPS from Cont. Operations growth. While overall EPS from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative EPS from Cont. Operations growth Comment
Leap Therapeutics Inc ' has realized cumulative trailing twelve months EPS loss from Cont. Operations of $ -3 in the Dec 31 2023 period.
The business is worsening as the cumulative EPS loss from Cont. Operations is becoming larger from $ -1.85 for the period from Sep 30 2023 to Dec 31 2022 and $ -0.46605191376226 for the twelve months ending in the quarter Dec 31 2022.

Leap Therapeutics inc achieved highest trailing twelve month year on year EPS from Cont. Operations growth. While overall EPS from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other EPS from Cont. Operations Growth
Major Pharmaceutical Preparations Industry EPS from Cont. Operations Growth Trends and Statistics
Healthcare Sector EPS from Cont. Operations Growth Statistics
EPS from Cont. Operations Growth Trends for overall market
LPTX's EPS from Cont. Operations Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking EPS from Cont. Operations Growth
Lowest Ranking EPS from Cont. Operations Growth
EPS from Cont. Operations Growth for LPTX's Competitors
EPS from Cont. Operations Growth for Leap Therapeutics Inc 's Suppliers
EPS from Cont. Operations Growth for LPTX's Customers

You may also want to know
LPTX's Annual Growth Rates LPTX's Profitability Ratios LPTX's Asset Turnover Ratio LPTX's Dividend Growth
LPTX's Roe LPTX's Valuation Ratios LPTX's Financial Strength Ratios LPTX's Dividend Payout Ratio
LPTX's Roa LPTX's Inventory Turnover Ratio LPTX's Growth Rates LPTX's Dividend Comparisons



Companies with similar EPS from Cont. Operations no change for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %EPS from Cont. Operations for the quarter ending Dec 31 2023
Axonics Inc 881.89%$ 881.894 
Livanova Plc869.22%$ 869.223 
Incyte Corporation601.43%$ 601.431 
Insulet Corporation504.30%$ 504.298 
Kiniksa Pharmaceuticals ltd 459.92%$ 459.916 
Organon and Co 401.69%$ 401.692 
Dexcom Inc 393.02%$ 393.024 
Nature s Sunshine Products inc 367.69%$ 367.687 
Inspire Medical Systems inc 359.55%$ 359.550 
National Healthcare Corp347.72%$ 347.720 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com